An independent guide for foreign investors, published by IMC, A Member Firm of Andersen Global connect@intuitconsultancy.comAbout IMCContact

Incentives · 1 February 2026

Budget 2026-27 lifts ECMS outlay to ₹40,000 crore and announces new schemes

Budget 2026-27 announced a larger ECMS outlay, Biopharma SHAKTI, a Container Manufacturing Scheme, three chemical parks, rare-earth corridors and an SEZ domestic sales facility.

Effective or announced 1 February 2026Impact for foreign investors: medium

What changed

Budget 2026-27, presented on 1 February 2026, announced an increase in the ECMS outlay from ₹22,919 crore to ₹40,000 crore; Biopharma SHAKTI (₹10,000 crore over five years); a Container Manufacturing Scheme (₹10,000 crore over five years); a construction and infrastructure equipment scheme; three chemical parks; rare-earth corridors in Odisha, Kerala, Andhra Pradesh and Tamil Nadu; and a one-time facility for SEZ manufacturers to sell into the domestic market at concessional duty. Public capex rose to ₹12.2 lakh crore.

Who it affects

Manufacturers in electronics, biopharma, containers, capital equipment and chemicals.

What to do

Wait for scheme guidelines before assuming eligibility. Where a scheme is announced but not operational, plan investment dates so that you can still qualify once it opens.

Planning your move into India?

Talk to IMC about your entry structure, approvals, incentives, tax and the first year of compliance.

Book a discovery conversation